Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Qiagen Webinar: Molecular Mechanisms of Neurodegeneration
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Immunology of Multiple Sclerosis.
Development of Guillain-Barré syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate.
Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.
Differences in the burden of psychiatric comorbidity in MS vs the general population.
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
A monoclonal natural human IgM protects axons in the absence of remyelination.
Biogen slips as FDA extends review of MS drug
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
Pediatric Multiple Sclerosis.
Tract-specific and age-related variations of the spinal cord microstructure: a multi-parametric MRI study using diffusion tensor imaging (DTI) and inhomogeneous magnetization transfer (ihMT).
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.
Multiple Sclerosis Society Education Conference

Pages